Skip to main content
OpenTrials

Clinical trial condition

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Explore clinical trials studying Metastatic Castration-resistant Prostate Cancer (mCRPC). Study availability and eligibility vary by location and protocol.

34 public trials 11 recruiting studies

Metastatic Castration-resistant Prostate Cancer (mCRPC) trial results

Conditions
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Locations
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Zhengzhou, Henan, China
  • Novartis Investigative Site Zhengzhou, Henan, China
  • Novartis Investigative Site Wuhan, Hubei, China
View all 17 locations
Conditions
Acute Myeloid Leukemia (AML), Blood Protein Disorders, Bone Marrow Diseases, +33 more
Locations
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • Oncology Institute of Hope and Innovation Pasadena, California, United States
  • Rocky Mountain Regional VA Medical Center Aurora, Colorado, United States
  • Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute) Denver, Colorado, United States
View all 46 locations
Conditions
Metastatic Castration-resistant Prostate Cancer (mCRPC), Nervous System Diseases, Neurologic Manifestations, +3 more
Locations
  • Site US10005 Anchorage, Alaska, United States
  • Site US10024 Detroit, Michigan, United States
  • Site US10001 New York, United States
  • Site US10014 New York, United States
View all 76 locations